Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-024640

Director bought 1,000 shares at $10.09 ($10,090)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Katz Ilan Director 2021-10-01 Purchase +1,000 $10.09 $10,090 1,000 D: show line 1 in the form
Open-market purchases · 1,000 sh · avg $10.09 · $10,090
Loading xslF345X03/ownership.xml…